Literature DB >> 8525810

A histochemical and electron microscopic study of skeletal and cardiac muscle from a Fabry disease patient and carrier.

M Uchino1, E Uyama, H Kawano, J Hokamaki, K Kugiyama, Y Murakami, H Yasue, M Ando.   

Abstract

Histochemical and electron microscopic studies were performed in an attempt to clarify the muscle pathology in an 18-year-old man with Fabry disease, showing proximal limb muscle atrophy, and his 52-year-old mother, who is a Fabry carrier with hypertrophic cardiomyopathy. Despite the relatively mild myopathic changes revealed by histochemistry, electron microscopy demonstrated the widespread accumulation of abundant lamellated bodies in myofibers, associated with increased glycogen granules and autophagic vacuoles. The cardiac muscle of the proband's mother revealed a mosaic pattern of normal-appearing and hypertrophic myofibers containing a number of ring-like, lamellated bodies. Although further studies are necessary to support our findings, skeletal muscle is apparently involved in patients with Fabry disease, and a mosaic pattern of cardiac muscle involvement possibly reflecting Lyonization, may be one of the characteristic findings of a Fabry disease carrier.

Entities:  

Mesh:

Year:  1995        PMID: 8525810     DOI: 10.1007/bf00296520

Source DB:  PubMed          Journal:  Acta Neuropathol        ISSN: 0001-6322            Impact factor:   17.088


  24 in total

1.  Ultrastructure of muscle and sensory nerve in Fabry's disease.

Authors:  F M Tomé; M Fardeau; G Lenoir
Journal:  Acta Neuropathol       Date:  1977-06-15       Impact factor: 17.088

2.  Carbamazepine for painful crises in Fabry's disease.

Authors:  H Shibasaki; T Tabira; N Inoue; I Goto; Y Kuroiwa
Journal:  J Neurol Sci       Date:  1973-01       Impact factor: 3.181

3.  Loss of small peripheral sensory neurons in Fabry disease. Histologic and morphometric evaluation of cutaneous nerves, spinal ganglia, and posterior columns.

Authors:  A Onishi; P J Dyck
Journal:  Arch Neurol       Date:  1974-08

4.  Dystrophin diagnosis: comparison of dystrophin abnormalities by immunofluorescence and immunoblot analyses.

Authors:  K Arahata; E P Hoffman; L M Kunkel; S Ishiura; T Tsukahara; T Ishihara; N Sunohara; I Nonaka; E Ozawa; H Sugita
Journal:  Proc Natl Acad Sci U S A       Date:  1989-09       Impact factor: 11.205

5.  Inclusion body myositis and Welander distal myopathy: a clinical, neurophysiological and morphological comparison.

Authors:  C Lindberg; K Borg; L Edström; A Hedström; A Oldfors
Journal:  J Neurol Sci       Date:  1991-05       Impact factor: 3.181

6.  Nature and frequency of mutations in the alpha-galactosidase A gene that cause Fabry disease.

Authors:  C M Eng; L A Resnick-Silverman; D J Niehaus; K H Astrin; R J Desnick
Journal:  Am J Hum Genet       Date:  1993-12       Impact factor: 11.025

7.  Involvement of peripheral nerve and muscle in Fabry's disease. Histologic, ultrastructural, and morphometric studies.

Authors:  A A Sima; D M Robertson
Journal:  Arch Neurol       Date:  1978-05

8.  Childhood acid maltase deficiency. A clinical, biochemical, and morphologic study of three patients.

Authors:  T Matsuishi; M Yoshino; K Terasawa; I Nonaka
Journal:  Arch Neurol       Date:  1984-01

9.  A histochemical and electron microscopic study of skeletal muscle in an adult case of Chédiak-Higashi syndrome.

Authors:  M Uchino; E Uyama; T Hirano; T Nakamura; T Fukushima; M Ando
Journal:  Acta Neuropathol       Date:  1993       Impact factor: 17.088

10.  Sequence variations in the first exon of alpha-galactosidase A.

Authors:  J P Davies; B G Winchester; S Malcolm
Journal:  J Med Genet       Date:  1993-08       Impact factor: 6.318

View more
  7 in total

1.  Awareness of Fabry disease among rheumatologists--current status and perspectives.

Authors:  Rolando Cimaz; Severine Guillaume; Max J Hilz; Gerd Horneff; Bernhard Manger; J Carter Thorne; Anette Torvin Møller; Nico M Wulffraat; Johannes Roth
Journal:  Clin Rheumatol       Date:  2011-04       Impact factor: 2.980

2.  Cardiac and skeletal myopathy in Fabry disease: a clinicopathologic correlative study.

Authors:  Cristina Chimenti; Luca Padua; Costanza Pazzaglia; Emanuela Morgante; Carlos Centurion; Daniela Antuzzi; Matteo A Russo; Andrea Frustaci
Journal:  Hum Pathol       Date:  2012-03-08       Impact factor: 3.466

3.  [Fabry disease: about an uncommon case].

Authors:  Hamid Jallal; Ali Khatori; Laila Bendriss
Journal:  Pan Afr Med J       Date:  2017-12-05

Review 4.  Fabry Disease: Molecular Basis, Pathophysiology, Diagnostics and Potential Therapeutic Directions.

Authors:  Ken Kok; Kimberley C Zwiers; Rolf G Boot; Hermen S Overkleeft; Johannes M F G Aerts; Marta Artola
Journal:  Biomolecules       Date:  2021-02-12

5.  The involvement of lysosomes in myocardial aging and disease.

Authors:  Alexei Terman; Tino Kurz; Bertil Gustafsson; Ulf T Brunk
Journal:  Curr Cardiol Rev       Date:  2008-05

6.  Effectiveness of agalsidase alfa enzyme replacement in Fabry disease: cardiac outcomes after 10 years' treatment.

Authors:  Christoph Kampmann; Amandine Perrin; Michael Beck
Journal:  Orphanet J Rare Dis       Date:  2015-09-29       Impact factor: 4.123

7.  Autophagy-lysosome pathway associated neuropathology and axonal degeneration in the brains of alpha-galactosidase A-deficient mice.

Authors:  Michael P Nelson; Tonia E Tse; Darrel B O'Quinn; Stefanie M Percival; Edgar A Jaimes; David G Warnock; John J Shacka
Journal:  Acta Neuropathol Commun       Date:  2014-02-14       Impact factor: 7.801

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.